David Rosen – AMRX history
- Issuer:
- AMNEAL PHARMACEUTICALS INC
- Quarters tracked:
- 13 (Q2 2023 → Q2 2026)
- Current shares:
- 10,168,660
- Current value:
- $176.02M
- Peak shares:
- 12,334,941 (Q3 2025)
- Overall change:
- +291%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 10,168,660 | $176.02M | $17.31 | -868,929 | -8% |
| Q1 2026 | 11,037,589 | $137.20M | $12.43 | -1,297,352 | -11% |
| Q4 2025 | 12,334,941 | $155.42M | $12.60 | 0 | 0% |
| Q3 2025 | 12,334,941 | $123.47M | $10.01 | +624,609 | +5% |
| Q2 2025 | 11,710,332 | $94.74M | $8.09 | +974,355 | +9% |
| Q1 2025 | 10,735,977 | $89.97M | $8.38 | +14,199 | 0% |
| Q4 2024 | 10,721,778 | $84.92M | $7.92 | 0 | 0% |
| Q3 2024 | 10,721,778 | $89.20M | $8.32 | 0 | 0% |
| Q2 2024 | 10,721,778 | $68.08M | $6.35 | +1,179,830 | +12% |
| Q1 2024 | 9,541,948 | $57.82M | $6.06 | +1,541,948 | +19% |
| Q4 2023 | 8,000,000 | $48.56M | $6.07 | +3,975,500 | +99% |
| Q3 2023 | 4,024,500 | $16.98M | $4.22 | +1,423,121 | +55% |
| Q2 2023 | 2,601,379 | $8.06M | $3.10 | — | NEW |